Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Origin Materials Inc (NASDAQ: ORGN) was $0.46 for the day, up 3.43% from the previous closing price of $0.45. In other words, the price has increased by $3.43 from its previous closing price. On the day, 0.72 million shares were traded. ORGN stock price reached its highest trading level at $0.4655 during the session, while it also had its lowest trading level at $0.4401.
Ratios:
Our analysis of ORGN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.28 and its Current Ratio is at 6.33. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for the company, BofA Securities on January 14, 2025, Downgraded its rating to Underperform and sets its target price to $1.50 from $2.50 previously.
On August 16, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $1.35 to $3.
Craig Hallum Downgraded its Buy to Hold on August 11, 2023, while the target price for the stock was maintained at $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 03 ’25 when Plavan Matthew T sold 150,000 shares for $0.55 per share. The transaction valued at 82,500 led to the insider holds 1,360,231 shares of the business.
MATT PLAVAN bought 150,000 shares of ORGN for $78,993 on Nov 03 ’25. On Aug 21 ’25, another insider, Lee Joshua C., who serves as the General Counsel of the company, sold 3,860 shares for $0.56 each. As a result, the insider received 2,177 and left with 689,084 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORGN now has a Market Capitalization of 69664968 and an Enterprise Value of 20997968. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.77 while its Price-to-Book (P/B) ratio in mrq is 0.24. Its current Enterprise Value per Revenue stands at 0.836 whereas that against EBITDA is -0.398.
Stock Price History:
The Beta on a monthly basis for ORGN is 1.00, which has changed by -0.63442624 over the last 52 weeks, in comparison to a change of 0.09654534 over the same period for the S&P500. Over the past 52 weeks, ORGN has reached a high of $1.36, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is -17.10%, while the 200-Day Moving Average is calculated to be -26.52%.
Shares Statistics:
ORGN traded an average of 1.06M shares per day over the past three months and 1152140 shares per day over the past ten days. A total of 150.53M shares are outstanding, with a floating share count of 136.38M. Insiders hold about 9.77% of the company’s shares, while institutions hold 10.87% stake in the company. Shares short for ORGN as of 1761868800 were 3189118 with a Short Ratio of 3.01, compared to 1759190400 on 3225672. Therefore, it implies a Short% of Shares Outstanding of 3189118 and a Short% of Float of 2.16.
